West Expands Dublin Facility to Support High-Volume Injectable Therapies, Including Diabetes and Obesity

2026-04-01 01:49:51

Abstract generation in progress

West Pharmaceutical Services has opened a new 165,000 square foot facility in Dublin, significantly expanding its contract services to meet the growing global demand for high-volume injectable treatments, particularly for diabetes and obesity. This expansion enhances West’s capabilities in drug handling, device assembly, and packaging, reinforcing its role in accelerating time to market for life-enhancing therapies. The new facility forms part of West Vantage™, the company’s comprehensive contract services business, offering a single-source solution from product conceptualization to regulatory support.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.